Global Clot Management Devices Market to Expand Rapidly as Industry Leader Medtronic Launches a revascularization device for treatment of acute ischemic stroke in the U.S.
A blood clot refers to clump of blood that has changed from a liquid to gel-like or semisolid state. The clotting is required process that can prevent individuals losing too much blood in certain instances. However, blood clot management devices are used to stop blood from clotting in arteries, which can obstruct or stop blood flow to various organs.
Rising incidence of coronary artery disease is expected to drive growth of the global clot management devices market during the forecast period. Coronary artery disease (CAD) refers to damage or disease in the heart’s major blood vessels. The primary cause is the build-up of plaque, which causes coronary arteries to narrow thereby limiting the blood flow to the heart. It does not necessarily have symptoms, although patients might experience chest pain and even heart attack. According to the Centers for Disease Control and Prevention (CDC), coronary artery disease is the most common heart disease in the U.S., killing around 365,914 people in 2017. According to the same source, around 18.2 million adults aged 20 years and above have CAD. Clot management devices are used to treat blood clots. Such a high prevalence of CAD has led to increased demand for clot management devices. Hence, these factors are expected to drive growth of the global clot management devices market during the forecast period. Furthermore, rising cases of periphery arterial diseases are expected to boost the global clot management devices market growth over the forecast period.However, high cost associated with these devices and lack of adequate healthcare services in emerging economies is expected to hamper the global clot management devices market growth over the forecast period.
Among regions, North America is expected to witness significant growth in the global clot management devices market during the forecast period. This is owing to rising geriatric population and the presence of robust healthcare infrastructure in the region. Furthermore, Asia Pacific is expected to register a lucrative growth rate over the forecast period, owing to rising cases of obesity, cardiovascular disease, and diabetes in the region.
Key players operating in the global clot management devices market are Medtronic, Straub Medical, Boston Scientific Corporation, iVascular, Teleflex, Vascular Solutions, Inc., Edwards Lifesciences, and LeMaitre Vascular.For instance, in April 2019, Medtronic launched Solitaire X revascularization device intended for treating acute ischemic stroke in the U.S.

Comments
Post a Comment